
    
      This study will test the efficacy and tolerance of patients with a high score of induration
      (modified Rodnan score > 20/54) Comparison : 34 patients with severe forms of cutaneous
      involvement will be evaluated in a double blind RCT comparing imatinib 400mg/j and placebo in
      a 6 month period. Efficacy will be assessed using a cutaneous induration scale and skin
      biopsy, and quality of life questionnaires.
    
  